Skip to main content
Glama

Data Cincinnati

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only and idempotent, and the description adds substantial behavioral detail: identifiers are source-labelled, unresolved identifiers appear under 'unresolved', ambiguous matches return 'figi_candidates', and LEI/FIGI enrichment degrades gracefully if upstream services fail. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with purpose and examples, then organized by supported type. Each parenthetical addresses a real edge case or decision point rather than padding, and no sentence feels extraneous for this level of complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter tool with no output schema, the description supplies enough context: what identifiers are returned per type, what happens on ambiguity, what happens on enrichment failure, and how to format inputs. An agent selecting or invoking the tool would not need external lookups.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though the schema covers both parameters 100%, the description adds critical semantics: pass only the entity name, use the exact issuer string for bonds, trailing security words match nothing, and accepted inputs include ticker, CIK, ISIN, or name. This materially reduces the chance of mis-invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a concrete action—resolving a user-spoken name to canonical/official identifiers—and enumerates supported entity types (company, drug) with example queries. It clearly frames this tool as the ID-from-name lookup among the sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit trigger: 'Use FIRST whenever you have a name but need an ID,' and provides detailed guidance for ambiguous bond names, non-ticker instruments, and drug names. It does not explicitly name alternative tools or state when not to use it, so it falls just short of full routing guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Data Cincinnati toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tool clusters have unclear boundaries: ask_pipeworx, ask_pipeworx_beta (explicitly identical), ask_pipeworx_grounded, and deep_research all route the same queries, and the five polymarket_* tools overlap in opportunity scanning. entity_profile, compare_entities, and recent_changes also pull similar company data, making tool selection genuinely ambiguous.

Naming Consistency4/5

All tool names are snake_case with a mostly verb-first convention (ask_pipeworx, scan_dependency, validate_claim, resolve_entity). A few noun-first names like polymarket_edges, entity_profile, and recent_alerts deviate slightly, but the pattern is predictable and readable throughout the 34-tool set.

Tool Count2/5

At 34 tools, the surface is heavy for what the server name (Data Cincinnati) implies, and only 3 tools actually relate to Cincinnati open data. The rest spans prediction markets, npm analysis, AI visibility, memory, and subscriptions, suggesting either scope creep or a misleading server name.

Completeness3/5

The research workflow is fairly covered: discovery (discover_tools, suggest_questions), query (ask_pipeworx), grounding (ask_pipeworx_grounded), verification (validate_claim), profiling (entity_profile), comparison (compare_entities), and monitoring (subscribe, recent_changes). However, notable gaps exist — no direct single-source raw query, no export/visualization, no subscription or alert management details beyond basic CRUD, and the Cincinnati-specific surface is thin (no geospatial or full-catalog access).

Resources